Company: ANIX
Filing Date: 2025-03-21
Form Type: 8-K
Source: 0001493152-25-011151
Chunk: 0

Company: Anixa Biosciences Inc
Filing Date: 2025-03-21
Form: 8-K
Item: Item 5.07
Chunk 0
---
Item 5.07

Submission of Matters to a Vote of Security Holders.

On
March 20, 2025, Anixa Biosciences, Inc. (the “ Company”) completed its 2025 annual meeting of stockholders (the “ Annual
Meeting”). The number of shares of stock entitled to vote at the Annual Meeting was 32,196,862 shares of common stock (the “ Voting
Stock”). The number of shares of Voting Stock present or represented by valid proxy at the Annual Meeting was 20,691,253 shares.
At the Annual Meeting, the Company’s stockholders (i) re-elected Dr. Amit Kumar, Dr. Arnold Baskies, Emily Gottschalk, and Lewis
H. Titterton, Jr. as directors, (ii) approved, on a non-binding, advisory basis, the Company’s executive compensation, (iii) ratified
the appointment of Haskell & White LLP as the Company’s independent registered public accounting firm for the fiscal year ending
October 31, 2025 and (iv) selected, on a non-binding, advisory basis, one year as the frequency of conducting future stockholder advisory
votes on named executive officer compensation. The following is a tabulation of the voting on the proposals presented at the Annual Meeting:

Proposal
No. 1 - Election of directors

Dr.
Amit Kumar, Dr. Arnold Baskies, Emily Gottschalk, and Lewis H. Titterton, Jr. were each re-elected to serve until the 2026 annual meeting
of stockholders or until their successors are elected and qualified or until their earlier resignation or removal. The voting results
were as follows:

  Nominee                      Shares Voted For      Shares Withheld      Broker Non-Vote  
 ───────────────────────────────────────────────────────────────────────────────────────────
  Dr. Amit Kumar                     10,047,287              102,451           10,541,515  
  Dr. Arnold Baskies                  9,958,291              191,447           10,541,515  
  Emily Gottschalk                    9,933,900              215,838           10,541,515  
  Lewis H. Titterton, Jr.             9,782,175              367,563           10,541,515  

Proposal
No. 2 - Approval, by non-binding advisory vote, of the Company’s executive compensation

The
Company’s executive compensation